Journal of Clinical Endocrinology & Metabolism, Vol 70, 1062-1067, Copyright © 1990 by Endocrine Society

ARTICLES

Insulin regulation of insulin-like growth factor-binding protein production in cultured HepG2 cells

CA Conover and PD Lee
Endocrine Research Unit, Mayo Clinic, Rochester, Minnesota 55905.

A human hepatoma cell line, HepG2, secretes a discrete insulin-like growth factor-binding protein (IGFBP-1) into serum-free medium, which is identical to the 25K mol wt BP in amniotic fluid and plasma. IGFBP-1 levels in vivo have been shown to be inversely correlated with circulating insulin concentrations. This study investigated the direct effects of insulin on IGFBP-1 production in vitro. Addition of insulin to HepG2 cultures induced a rapid dose-dependent decrease in IGFBP-1 synthesis and secretion independent of the glucose concentration in the medium. As assessed by ligand binding and specific RIA, levels of IGFBP- 1 were 20-50% of control levels in 18-h conditioned medium from insulin- treated cells. Monoclonal antibody studies indicated that the suppressive effect of insulin on IGFBP-1 synthesis was mediated through specific interaction with the insulin receptor. Therefore, HepG2 cells respond to insulin by altering the synthesis and secretion of IGFBP-1 in a manner that mimics many of the changes in plasma IGFBP-1 levels observed in vivo and provide an in vitro model for studies of IGFBP-1 biosynthesis.

This article has been cited by other articles:

				T. G. Nielsen, A. Olsen, J. Christensen, K. Overvad, and A. Tjonneland Dietary Carbohydrate Intake Is Not Associated with the Breast Cancer Incidence Rate Ratio in Postmenopausal Danish Women J. Nutr., January 1, 2005; 135(1): 124 - 128. [Abstract] [Full Text] [PDF]

				C. R. Jonas, M. L. McCullough, L. R. Teras, K. A. Walker-Thurmond, M. J. Thun, and E. E. Calle Dietary Glycemic Index, Glycemic Load, and Risk of Incident Breast Cancer in Postmenopausal Women Cancer Epidemiol. Biomarkers Prev., June 1, 2003; 12(6): 573 - 577. [Abstract] [Full Text] [PDF]

				V. De Leo, A. la Marca, G. Morgante, L. Ciotta, L. Mencaglia, A. Cianci, and F. Petraglia Clomiphene citrate increases insulin-like growth factor binding protein-1 and reduces insulin-like growth factor-I without correcting insulin resistance associated with polycystic ovarian syndrome Hum. Reprod., November 1, 2000; 15(11): 2302 - 2305. [Abstract] [Full Text] [PDF]

				J. Sugawara, D.-S. Suh, G. H. Faessen, L.-F. Suen, T. Shibata, F. Kaper, A. J. Giaccia, and L. C. Giudice Regulation of Insulin-Like Growth Factor-Binding Protein-1 by Nitric Oxide under Hypoxic Conditions J. Clin. Endocrinol. Metab., August 1, 2000; 85(8): 2714 - 2721. [Abstract] [Full Text]

				A. M. Mirza, S. Ezzat, and A. A. Axelrad Insulin-Like Growth Factor Binding Protein-1 Is Elevated in Patients With Polycythemia Vera and Stimulates Erythroid Burst Formation In Vitro Blood, March 15, 1997; 89(6): 1862 - 1869. [Abstract] [Full Text] [PDF]

				E. Carmina, F. Z. Stanczyk, R. S. Morris, P. D. K. Lee, G. Savjani, and R. A. Lobo Altered Regulation of Insulin-Like Growth Factor Binding Protein-I in Patients With Polycystic Ovary Syndrome Reproductive Sciences, November 1, 1995; 2(6): 743 - 747. [Abstract] [PDF]